We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$7.57B
AUM Growth
+$643M
(+9.3%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$71M |
| 2 |
Baxter International
BAX
|
+$60.7M |
| 3 |
T-Mobile US
TMUS
|
+$60.1M |
| 4 |
Perrigo
PRGO
|
+$53.7M |
| 5 |
NRG Energy
NRG
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$68.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$53.3M |
| 3 |
Avient
AVNT
|
+$45.7M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$45.6M |
| 5 |
BHI
Baker Hughes
BHI
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.11% |
| 2 | Industrials | 11.84% |
| 3 | Consumer Discretionary | 11.65% |
| 4 | Technology | 10.61% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARG
326
DELISTED
Airgas Inc
ARG
| $4.53M | 0.06% |
+39,319
| New | +$4.43M |
|
|
WX
327
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $4.52M | 0.06% |
134,301
-69,333
| -34% | -$2.45M |
|
328
Alto Ingredients
ALTO
$392M
| $4.47M | 0.06% |
+432,703
| New | +$5.28M |
|
329
Johnson Controls International
JCI
$93.1B
| $4.46M | 0.06% |
+88,059
| New | +$4.3M |
|
|
DATA
330
DELISTED
Tableau Software, Inc.
DATA
| $4.39M | 0.06% |
51,739
+46,494
| +886% | +$3.7M |
|
|
EJ
331
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
| $4.33M | 0.06% |
598,572
-628,853
| -51% | -$5.39M |
|
332
Church & Dwight Co
CHD
$24.6B
| $4.32M | 0.06% |
109,494
-77,188
| -41% | -$2.85M |
|
|
WP
333
DELISTED
Worldpay, Inc.
WP
| $4.27M | 0.06% |
+125,976
| New | +$4.07M |
|
334
Agnico Eagle Mines
AEM
$83.8B
| $4.25M | 0.06% |
+170,615
| New | +$4.44M |
|
335
Applied Materials
AMAT
$424B
| $4.24M | 0.06% |
170,208
-151,536
| -47% | -$3.42M |
|
336
Delek US
DK
$3.66B
| $4.22M | 0.06% |
+154,590
| New | +$4.68M |
|
337
HCA Healthcare
HCA
$88.7B
| $4.19M | 0.06% |
57,134
-148,063
| -72% | -$10.4M |
|
|
PXD
338
DELISTED
Pioneer Natural Resource Co.
PXD
| $4.17M | 0.06% |
+28,048
| New | +$4.63M |
|
|
VR
339
DELISTED
Validus Hold Ltd
VR
| $4.13M | 0.05% |
99,449
-297,347
| -75% | -$12M |
|
340
Dillards
DDS
$9.63B
| $4.1M | 0.05% |
32,728
+29,567
| +935% | +$3.3M |
|
|
AAN.A
341
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $4.07M | 0.05% |
+133,226
| New | +$4.07M |
|
342
Ribbon Communications
RBBN
$384M
| $4.05M | 0.05% |
204,165
+79,001
| +63% | +$1.4M |
|
|
SIAL
343
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $4.02M | 0.05% |
+29,258
| New | +$3.98M |
|
|
CPHD
344
DELISTED
Cepheid Inc
CPHD
| $4M | 0.05% |
+73,838
| New | +$3.73M |
|
|
FEIC
345
DELISTED
FEI COMPANY
FEIC
| $4M | 0.05% |
44,219
-35,090
| -44% | -$2.93M |
|
346
Chipotle Mexican Grill
CMG
$43.7B
| $3.99M | 0.05% |
+291,400
| New | +$3.81M |
|
347
Northrop Grumman
NOC
$79.2B
| $3.99M | 0.05% |
+27,049
| New | +$3.71M |
|
|
CAMP
348
DELISTED
CalAmp Corp.
CAMP
| $3.98M | 0.05% |
9,464
+2,005
| +27% | +$855K |
|
349
ATI
ATI
$28B
| $3.97M | 0.05% |
+114,143
| New | +$3.77M |
|
|
CIR
350
DELISTED
CIRCOR International, Inc
CIR
| $3.96M | 0.05% |
+65,661
| New | +$4.32M |
|
Similar funds
Marshall Wace's Q4 2014 Portfolio in Review
As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.
- Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
- Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
- Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
- Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
- Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
- Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
- Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.
Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.